ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

フェニンダミン

Phenindamine

HCID 11291
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
82-88-2
標準SMILES
CN1CCC2=C(C1)C(c1ccccc1)c1ccccc12
InChIKey
ISFHAYSTHMVOJR-UHFFFAOYSA-N
分子式
C19H19N
平均分子量
261.4 g/mol
単同位体質量
261.15174961

概要

Phenindamine is an indene.

名称と識別子

優先名称
Phenindamine
IUPAC
2-methyl-9-phenyl-1,3,4,9-tetrahydroindeno[2,1-c]pyridine
現地名
フェニンダミン
英語名
phenindamine
分子式
C19H19N
分子量
261.36

名称と別名

PhenindamineThephorin82-88-2FenindaminaPhenindaminum772BQ8KSSTNU-15042,3,4,9-Tetrahydro-2-methyl-9-phenyl-1H-indeno(2,1-c)pyridine1H-Indeno(2,1-c)pyridine, 2,3,4,9-tetrahydro-2-methyl-9-phenyl-DTXSID00234521H-Indeno[2,1-c]pyridine, 2,3,4,9-tetrahydro-2-methyl-9-phenyl-2,3,4,9-Tetrahydro-2-methyl-9-phenyl-1H-indeno[2,1-c]pyridine
名称をさらに表示
フェニンダミン2,3,4,9-テトラヒドロ-9-(フェニル)-2-メチル-1H-インデノ[2,1-c]ピリジンテホリン2,3,4,9-テトラヒドロ-2-メチル-9-フェニル-1H-インデノ[2,1-c]ピリジン2-メチル-9-フェニル-1H,2H,3H,4H,9H-インデノ[2,1-c]ピリジンphenindamine USP/EP/BPPhenindamine Hydrogen Tartrate2-methyl-9-phenyl-1,3,4,9-tetrahydroindeno[2,1-c]pyridine1H-Indeno2,1-cpyridine, 2,3,4,9-tetrahydro-2-methyl-9-phenyl-
2-METHYL-9-PHENYL-1H,2H,3H,4H,9H-INDENO[2,1-C]PYRIDINE2-methyl-9-phenyl-1H,2H,3H,4H,9H-indeno(2,1-c)pyridineRefChem:172693DTXCID403452R06AX042,3,4,9-tetrahydro-2-methyl-9-phenyl-lH-indeno-(2,1-c)pyridine201-443-4Fenindamina [INN-Spanish]

物性

構造計算による物性

XLogP
3.1
極性表面積
3.2 Ų
水素結合供与体数
0
水素結合受容体数
1
回転可能結合数
1
重原子数
20
形式電荷
0
複雑度
391

実験および物理化学的性質

Solubility2.77e-02 g/L
Human Drugs · 2 件

Breast Feeding; Lactation; Milk, Human; Antihistamines

Pharmaceuticals

Melting Point91 °C
Physical DescriptionSolid

物理化学的性質

融点
90 · 90-91°
比重(密度)
1.17 · 1.17
酸解離定数(Pka)
8.11 · pKa 8.11±0.08(H2O,t undefined,I=0.30(NaCl)) (Uncertain)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

危険有害性情報

Regulatory Information1H-Indeno2,1-cpyridine, 2,3,4,9-tetrahydro-2-methyl-9-phenyl-: Does not have an individual approval but may be used under an appropriate group standard

毒性情報

Toxicity Summary · 1 件

Antihistamines such as phenindamine appear to compete with histamine for histamine H1- receptor sites on effector cells. The antihistamines antagonize those pharmacological effects of histamine which are mediated through activation of H1- receptor sites and thereby reduce the intensity of allergic reactions and tissue injury response involving histamine release.

Signs and SymptomsSymptoms of a phenindamine overdose include extreme sleepiness, confusion, weakness, ringing in the ears, blurred vision, large pupils, dry mouth, flushing, fever, shaking, insomnia, hallucinations, and possibly seizures.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

化学と産業

薬理情報

ATC Code · 2 件

R - Respiratory system

QR - Respiratory system

Pharmacodynamics · 1 件

Phenindamine is an antihistamine. Phenindamine blocks the effects of the naturally occurring chemical histamine in your body. Allergies are caused by an excessive type 1 hypersensitivity response of the body to allergens, mediated by inappropriate histamine signalling. By inhibiting the binding of histamine, antihistamines decrease the normal histamine response from cells, consequently decreasing allergic symptoms.

Mechanism of Action · 1 件

Antihistamines such as phenindamine appear to compete with histamine for histamine H1- receptor sites on effector cells. The antihistamines antagonize those pharmacological effects of histamine which are mediated through activation of H1- receptor sites and thereby reduce the intensity of allergic reactions and tissue injury response involving histamine release.

MeSH Pharmacological Classification · 1 件

Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.

Cellular LocationsMembrane
Metabolite PathwaysPhenindamine H1-Antihistamine Action

用途と製造

UsesUsed to treat sneezing, runny nose, itching, watery eyes, hives, rashes, itching, and other symptoms of allergies and the common cold.

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
82-88-2
PubChem CID
11291
DTXSID
DTXSID0023452
ChEMBL
CHEMBL278398
ChEBI
CHEBI:8065
UNII
772BQ8KSST
EC Number
201-443-4
Nikkaji
J4.619A
Use Classification
Pharmaceuticals

上流・下流製品情報

上流原料

メチルアミン水酸化ナトリウム水素チオシアノカリウムアセトフェノン臭化水素酸ホルマリン

サプライヤー10 社

南京世洲生物科技有限公司025-025-85560043 17301488900 · [email protected]
上海赛可锐生物科技有限公司021-58000709 13120558703 · [email protected]
陕西缔都医药化工有限公司+86-29-87569262 +86-15003564040 · [email protected]
上海陶术生物科技股份有限公司13564774135 · [email protected]
南京艾瑞博生物科技有限公司19951442182 · [email protected]
陕西缔都医药化工有限公司029-029-029-81148696 18161915376 · [email protected]
TargetMol中国(陶术生物)4008200310 15002144251 · [email protected]
铭龙(咸宁)医药有限公司186-7296-9259 18771307593 · [email protected]
DAYANG CHEM (HANGZHOU) CO.,LTD+86-88938639 +86-17705817739 · [email protected]
南京世洲生物科技有限公司18351873721 · [email protected]